- Excellent financial health (Piotroski 7/9)
- Beat earnings estimates in 3 of the last 4 quarters
- Strong return on equity of 68.0%
AbbVie stock price up 2.04% on Tuesday
(Updated on Jun 23, 2026)
The AbbVie stock price gained 2.04% on the last trading day (Tuesday, 23rd Jun 2026), rising from $230.06 to $234.76. During the last trading day the stock fluctuated 1.73% from a day low at $231.30 to a day high of $235.31. The price has been going up and down for this period, and there has been a 5.24% gain for the last 2 weeks. Volume fell on the last day by -294 thousand shares and in total, 7 million shares were bought and sold for approximately $1.69 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $234.94 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 8.82% during the next 3 months and, with a 90% probability hold a price between $227.81 and $255.66 at the end of this 3-month period.
ABBV Signals & Forecast
The AbbVie stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $224.92 and $216.14. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 8.37%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for AbbVie stock
On the downside, the stock finds support just below today's level from accumulated volume at $211.33 and $206.47. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AbbVie finds support just below today's level at $211.33. If this is broken, then the next support from accumulated volume will be at $206.47 and $204.35.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $4.01 (1.73%) between high and low. For the last week, the stock has had daily average volatility of 2.68%.
Our recommended stop-loss: $227.39 (-3.14%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 2 days ago.)
Trading Expectations (ABBV) For The Upcoming Trading Day Of Wednesday 24th
For the upcoming trading day on Wednesday, 24th we expect AbbVie Inc to open at $233.79, and during the day (based on 14 day Average True Range), to move between $231.74 and $237.78, which gives a possible trading interval of +/-$6.04 (+/-2.61%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 2.61% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $211.33, some $23.43 (9.98%) from the current price of $234.76, our system finds the risk reward attractive.
Dividend Warning For ABBV
Dividend coming up for ABBV: Ex-dividend date (Wednesday 15th July, 2026) is 20 days away. The dividend is $1.73.Is AbbVie Inc stock A Buy?
AbbVie holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Current score:
5.621
Strong Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on June 24, 2026 - $233.79 ( 0.414%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
ABBV Performance
Trading levels for ABBV
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 237.79 | 1.29% |
| R2 | 236.26 | 0.640% |
| R1 | 235.32 | 0.238% |
| Price | 234.76 | |
| S1 | 232.26 | -1.07% |
| S2 | 231.31 | -1.47% |
| S3 | 229.78 | -2.12% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 234.76 | |
| S1 | 211.33 | -9.98% |
| S2 | 206.47 | -12.05% |
| S3 | 204.35 | -12.95% |
ABBV Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jun 18, 2026 | Jul 15, 2026 | Aug 14, 2026 | $1.73 | 0.752% |
| 2 | Feb 19, 2026 | Apr 15, 2026 | May 15, 2026 | $1.73 | 0.754% |
| 3 | Oct 31, 2025 | Jan 16, 2026 | Feb 17, 2026 | $1.73 | 0.82% |
| 4 | Sep 05, 2025 | Oct 15, 2025 | Nov 14, 2025 | $1.64 | 0.782% |
| 5 | Jun 20, 2025 | Jul 15, 2025 | Aug 15, 2025 | $1.64 | 0.88% |
FAQ
Click here for our free guide on how to buy AbbVie Stock.
Buy ABBV